Literature DB >> 12383922

Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis.

Valerio Leoni1, Thomas Masterman, Ulf Diczfalusy, Giancarlo De Luca, Jan Hillert, Ingemar Björkhem.   

Abstract

24S-Hydroxycholesterol (24S-OH-chol) is almost exclusively derived from the brain and the levels of this oxysterol in the circulation may be used as a marker for changes in the turnover of brain cholesterol. In the present study we assayed plasma and cerebrospinal fluid 24S-OH-chol in patients with multiple sclerosis (n = 118) at different stages of the disease. In the oldest groups of patients the levels of 24S-OH-chol were significantly lower than in the controls, possibly reflecting loss of neuronal cells responsible for the synthesis. There was a significant inverse relation between the expanded disability status scale-grade of the disease and the plasma cholesterol related levels of 24S-OH-chol. There was a tendency to increased plasma levels of 24S-OH-chol in the younger patients and almost all of the high levels were found in the patients in the 3rd and 4th decades of life. Increased levels were only found in patients with positive cranial magnetic resonance imaging. The possibility is discussed that plasma levels of 24S-OH-chol may add significantly to existing methods used for evaluation of the different phases of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383922     DOI: 10.1016/s0304-3940(02)00887-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

Review 1.  Body fluid biomarkers for multiple sclerosis--the long road to clinical application.

Authors:  Charlotte E Teunissen; Arjan Malekzadeh; Cyra Leurs; Claire Bridel; Joep Killestein
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

Review 2.  Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.

Authors:  Nabil K El Ayoubi; Samia J Khoury
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

3.  Interdependence of oxysterols with cholesterol profiles in multiple sclerosis.

Authors:  Shreya Mukhopadhyay; Kelly Fellows; Richard W Browne; Prachi Khare; Sandhya Krishnan Radhakrishnan; Jesper Hagemeier; Bianca Weinstock-Guttman; Robert Zivadinov; Murali Ramanathan
Journal:  Mult Scler       Date:  2016-09-28       Impact factor: 6.312

Review 4.  Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Authors:  Itay Raphael; Johanna Webb; Olaf Stuve; William Haskins; Thomas Forsthuber
Journal:  Expert Rev Clin Immunol       Date:  2014-12-18       Impact factor: 4.473

Review 5.  Wnt and lithium: a common destiny in the therapy of nervous system pathologies?

Authors:  Delphine Meffre; Julien Grenier; Sophie Bernard; Françoise Courtin; Todor Dudev; Ghjuvan'Ghjacumu Shackleford; Mehrnaz Jafarian-Tehrani; Charbel Massaad
Journal:  Cell Mol Life Sci       Date:  2013-06-09       Impact factor: 9.261

Review 6.  Brain cholesterol metabolism, oxysterols, and dementia.

Authors:  Timothy M Hughes; Caterina Rosano; Rhobert W Evans; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 7.  Rediscovery of cerebrosterol.

Authors:  Ingemar Björkhem
Journal:  Lipids       Date:  2007-01-23       Impact factor: 1.880

8.  Statin therapy inhibits remyelination in the central nervous system.

Authors:  Veronique E Miron; Simone P Zehntner; Tanja Kuhlmann; Samuel K Ludwin; Trevor Owens; Timothy E Kennedy; Barry J Bedell; Jack P Antel
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

Review 9.  Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain.

Authors:  David W Russell; Rebekkah W Halford; Denise M O Ramirez; Rahul Shah; Tiina Kotti
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  Cross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte death.

Authors:  Amalia Trousson; Joelle Makoukji; Patrice X Petit; Sophie Bernard; Christian Slomianny; Michael Schumacher; Charbel Massaad
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.